Thieme E-Books & E-Journals -
Drug Res (Stuttg) 2013; 63(06): 293-299
DOI: 10.1055/s-0033-1337927
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Disposition of the New Potent Acetylcholinesterase Inhibitor 8-[3-[1-[(3-fluorophenyl)methyl]-4-piperidiny]-1-oxopropyl]-1, 2, 5, 6-tetrahydro-4H-pyrrolo [3, 2, 1-ij] quinolin-4-one (TAK-802) in Rats, Dogs and Monkeys

Authors

  • M. Kakehi

    1   Drug Metabolism and Pharmacokinetics Research Laboratory, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan
  • Y. Tagawa

    1   Drug Metabolism and Pharmacokinetics Research Laboratory, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan
  • T. Kondo

    1   Drug Metabolism and Pharmacokinetics Research Laboratory, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan
  • S. Asahi

    1   Drug Metabolism and Pharmacokinetics Research Laboratory, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan